Research
Gonadorelin — living evidence map
The Atlas page holds the claims; this is how its evidence evolved.
Summary
Gonadotropin-releasing hormone is a hypothalamic decapeptide; a 2022 review marks more than fifty years of research since its discovery. · pmid:35726373
Identity
PubChem CID 638793: Gonadorelin, C55H75N17O13, 1182.3 g/mol. · pubchem:638793
CAS registry number 33515-09-2. · pubchem:638793
Where the evidence actually sits
Proportion of the 1 claim about Gonadorelin standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.
Living evidence history
1 resolved citation, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.
Structure
No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Gonadorelin yet.
Dose evidence, rung by rung
A studied human dose exists on file. Open the rung: the dose is the paper's, in its context, never PepJunkie's.
- Approved-label dose · a resolved regulatory document names a labelled dose
nothing resolved on this rung
- Studied human doses · resolved human studies at the established tier
- The fifty years following the discovery of gonadotropin-releasing hormone. · pmid 35726373 · 2022
- Observational evidence · resolved human data at the emerging tier: thin, or contested
nothing resolved on this rung
- Community-reported protocols · protocol propositions from distinct members, counted once per human
nothing resolved on this rung
- Preclinical evidence · resolved animal, cell or mechanistic work
nothing resolved on this rung
1 resolved citation, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.